George Clark
Comptroller/Controller/Auditor at BIOHAVEN LTD.
Net worth: 2 M $ as of 2024-04-29
Profile
George Clark currently works at Biohaven Ltd., as Chief Accounting Officer & Vice President.
Mr. Clark also formerly worked at KPMG LLP, as Senior Manager-Hartford Audit Practice and Biohaven Pharmaceutical Holding Co. Ltd., as Vice President-Finance from 2019 to 2021.
Mr. Clark received his undergraduate degree and graduate degree from the University of Connecticut.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOHAVEN LTD.
0.07% | 2024-01-01 | 64,285 ( 0.07% ) | 2 M $ | 2024-04-29 |
George Clark active positions
Companies | Position | Start |
---|---|---|
BIOHAVEN LTD. | Comptroller/Controller/Auditor | - |
Former positions of George Clark
Companies | Position | End |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 2022-10-02 |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of George Clark
University of Connecticut | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIOHAVEN LTD. | Health Technology |
Private companies | 2 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- George Clark